We are thrilled to share our latest interview featuring Prof Christopher Chen, principal investigator of “Alzheimer’s Disease THErapy With NEuroaid (ATHENE): A Randomized Double-Blind Delayed-Start Trial”, published in the Journal of the American Medical Directors Association.

This study provides evidence for the use of NeuroAiD as an add-on to standard Alzheimer’s Disease treatment. NeuroAiD shows a favourable tolerability profile while improving cognitive functions upon early initiation.

·       Watch the video at https://www.youtube.com/watch?v=LJ7pBbqRL-Q

·       Read the full article at https://www.jamda.com/article/S1525-8610(21)00938-5/fulltext

·       Learn more about NeuroAiD at www.moleac.com